Market Closed

BNTX
BioNTech SE
$ 85.60
0.66%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

BioNTech SE News

Latest BioNTech SE Stock News & BNTX Headlines

BioNTech Q3: Bristol Myers Revenue Masks A Narrowing Oncology Bet (Rating Downgrade)
11 days ago | seekingalpha.com
BioNTech SE (BNTX) Q3 2026 Earnings Call Transcript
11 days ago | seekingalpha.com
BioNTech Q3 Earnings Call Highlights
11 days ago | marketbeat.com
BioNTech Announces Third Quarter 2026 Financial Results and Corporate Update
12 days ago | globenewswire.com
BioNTech, Gilead to test drug combination in advanced breast cancer trial
24 days ago | reuters.com
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
a month ago | globenewswire.com
BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026
a month ago | globenewswire.com
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy?
a month ago | fool.com
BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX)
a month ago | prnewswire.com
BioNTech Provides Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy Candidate BNT113 in Metastatic HPV16-positive Head and Neck Cancer
a month ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

BNTX
BioNTech SE
$ 85.60
0.66%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago